R&D
Copyright(c)2019 Qilu Pharmaceutical Co., Ltd. 鲁ICP备06006222号 Headquarter Address: 8888 Lvyou Road, High-tech Zone, Jinan, 250104, China
PRODUCTS
MANUFACTURING
NEWS
CONTACT US
ABOUT US
Qilu Pharma Announces Launch of a Generic Version of Vesicare® in the United States
Classification:
Company news
Author:
Source:
QILU PHARMACEUTICAL
Release time：
2019/05/20 09:51
Page view
[Abstract]:
May 20, 2019—Qilu Pharmaceutical today announced the U.S. approval and launch of Solifenacin Succinate Tablets, which makes the third Day 181 launched product for Qilu in US.
Up to now, Qilu has launched thirteen products in US and among them, ten products are the injectables.
NEWS